跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MONTELAIR TABLET 10MG - HSA Drug Approval Details
Approvals
/
HSA
/
MONTELAIR TABLET 10MG
Approved
THERAPEUTIC
MONTELAIR TABLET 10MG
HOVID BHD (MALAYSIA)
🇸🇬 Health Sciences Authority
Approval Date
May 26, 2015
Approval ID
fcb412c5782e9d75
Company
HOVID BHD (MALAYSIA)
Type
Therapeutic
Approval Details
Approval Id
fcb412c5782e9d75
Drug Name
MONTELAIR TABLET 10MG
Product Name
MONTELAIR TABLET 10MG
Approval Number
SIN14788P
Approval Date
2015-05-26
Registrant
GOLDPLUS UNIVERSAL PTE LTD
Licence Holder
GOLDPLUS UNIVERSAL PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
R03DC03
Atc Item Name
montelukast
Pharma Manufacturer Name
GOLDPLUS UNIVERSAL PTE LTD
Company Detail Path
/organization/goldplus-universal-pte-ltd
Active Ingredients
Montelukast Sodium 10.40mg eqv Montelukast
10mg
MONTELUKAST SODIUM 10.4 MG EQV MONTELUKAST
10 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 26, 2015
Approval ID
fcb412c5782e9d75
Type
Therapeutic
Back to HSA Approvals